CSL Behring is a global biotherapeutics leader focused on discovering, developing, and delivering innovative therapies for people living with rare and serious diseases. The company’s work is grounded in a promise to help save lives and improve the health of patients around the world.
This role offers the opportunity to make a meaningful impact on commercial execution by helping CSL Behring design and administer incentive compensation programs that motivate performance, support business goals, and reinforce a consistent, transparent experience for the field.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.